Performance of a vancomycin dosage regimen developed for obese patients (Q84174548)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610026 AND SRC:MED&resulttype=core&format=json

1 February 2020

title

Performance of a vancomycin dosage regimen developed for obese patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610026 AND SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

David C. Reynolds

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22610026

1 January 2025

Laura H. Waite

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22610026

1 January 2025

Donald P. Alexander

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22610026

1 January 2025

C. Andrew DeRyke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22610026

1 January 2025

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22610026

1 January 2025

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610026 AND SRC:MED&resulttype=core&format=json

full work available at URL

1 February 2020

http://academic.oup.com/ajhp/article-pdf/69/11/944/28455017/ajhp0944.pdf

1 reference

American Journal of Health-System Pharmacy

1 January 2025

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610026 AND SRC:MED&resulttype=core&format=json

1 February 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610026 AND SRC:MED&resulttype=core&format=json

1 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610026 AND SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

944-950

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610026 AND SRC:MED&resulttype=core&format=json

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

1 February 2020

cites work

1 reference

Vancomycin dosing in morbidly obese patients

31 March 2020

1 reference

Vancomycin pharmacokinetics in normal and morbidly obese subjects

31 March 2020

1 reference

Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique

31 March 2020

1 reference

Determining vancomycin clearance in an overweight and obese population

31 March 2020

1 reference

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

31 March 2020

1 reference

Prediction of creatinine clearance from serum creatinine

31 March 2020

1 reference

Analysis of various creatinine clearance formulas in predicting gentamicin elimination in patients with low serum creatinine.

31 March 2020

1 reference

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices

31 March 2020

1 reference

Vancomycin: we can't get there from here

31 March 2020

1 reference

Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight.

31 March 2020

1 reference

The Sizes and Numbers of Cells in Visceral Organs in Human Obesity

31 March 2020

1 reference

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

31 March 2020

1 reference

Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy

31 March 2020

1 reference

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients

31 March 2020

1 reference

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

31 March 2020

1 reference

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

31 March 2020

1 reference

Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy

31 March 2020

1 reference

A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia

31 March 2020

1 reference

Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity

31 March 2020

16

1 reference

1 January 2025

Identifiers

DOI

10.2146/AJHP110324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22610026 AND SRC:MED&resulttype=core&format=json

1 February 2020

1 reference